CD70 and PD-L1 in anaplastic thyroid cancer - promising targets for immunotherapy.

about

Refractory thyroid carcinoma: which systemic treatment to use?CTLA-4 and PD-1 Ligand Gene Expression in Epithelial Thyroid Cancers

P2860

Q49335901-6E93A3E8-23D9-41AD-82CA-9A9AB4247838 Q56891239-9716479B-B490-4FE3-8775-86A304F77426

P2860

CD70 and PD-L1 in anaplastic thyroid cancer - promising targets for immunotherapy.

Item

http://www.wikidata.org/entity/Q38850275

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

CD70 and PD-L1 in anaplastic thyroid cancer - promising targets for immunotherapy.

@en

type

Item

label

CD70 and PD-L1 in anaplastic thyroid cancer - promising targets for immunotherapy.

@en

prefLabel

CD70 and PD-L1 in anaplastic thyroid cancer - promising targets for immunotherapy.

@en

P1476

CD70 and PD-L1 in anaplastic thyroid cancer - promising targets for immunotherapy.

@en

P2093

Astrid De Meulenaere

http://www.w3.org/2001/XMLSchema#string

Christian Rolfo

http://www.w3.org/2001/XMLSchema#string

Esther Hauben

http://www.w3.org/2001/XMLSchema#string

Karen Silence

http://www.w3.org/2001/XMLSchema#string

Patrick Pauwels

http://www.w3.org/2001/XMLSchema#string

Sylvie Rottey

http://www.w3.org/2001/XMLSchema#string

Vasiliki Siozopoulou

http://www.w3.org/2001/XMLSchema#string

P2860

CD70+ non-Hodgkin lymphoma B cells induce Foxp3 expression and regulatory function in intratumoral CD4+CD25 T cells

Development of PD-1/PD-L1 Pathway in Tumor Immune Microenvironment and Treatment for Non-Small Cell Lung Cancer

Anti-CD70 antibodies: a potential treatment for EBV+ CD70-expressing lymphomas

Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients

Phase I dose-escalation study of SGN-75 in patients with CD70-positive relapsed/refractory non-Hodgkin lymphoma or metastatic renal cell carcinoma.

Rapid KRAS, EGFR, BRAF and PIK3CA mutation analysis of fine needle aspirates from non-small-cell lung cancer using allele-specific qPCR.

Update on anaplastic thyroid carcinoma: morphological, molecular, and genetic features of the most aggressive thyroid cancer.

CD27 and CD70 in T cell and B cell activation.

Macrophage regulation of tumor responses to anticancer therapies.

Unlocking the potential of CD70 as a novel immunotherapeutic target for non-small cell lung cancer

P304

357-365

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/HIS.13230

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

E Smits

Julie Jacobs

Karen Zwaenepoel

P577

2017-04-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28383817

http://www.w3.org/2001/XMLSchema#string

CD70 and PD-L1 in anaplastic thyroid cancer - promising targets for immunotherapy.

about

P2860

P2860

CD70 and PD-L1 in anaplastic thyroid cancer - promising targets for immunotherapy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698